GSE SYSTEMS INC, 10-Q filed on 15 May 23
v3.23.1
Document and Entity Information - shares
3 Months Ended
Mar. 31, 2023
Apr. 30, 2023
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Period End Date Mar. 31, 2023  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q1  
Document Transition Report false  
Entity File Number 001-14785  
Entity Registrant Name GSE Systems, Inc.  
Entity Central Index Key 0000944480  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 52-1868008  
Entity Address, Address Line One 6940 Columbia Gateway Dr.  
Entity Address, Address Line Two Suite 470  
Entity Address, City or Town Columbia  
Entity Address, State or Province MD  
Entity Address, Postal Zip Code 21046  
City Area Code 410  
Local Phone Number 970-7800  
Title of 12(b) Security Common Stock, $0.01 Par Value  
Trading Symbol GVP  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   23,560,808
v3.23.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 1,265 $ 2,789
Restricted cash, current 500 1,052
Contract receivables, net of allowance for credit loss 10,464 10,064
Prepaid expenses and other current assets 1,282 2,165
Total current assets 13,511 16,070
Equipment, software and leasehold improvements, net 724 772
Software development costs, net 567 574
Goodwill 6,299 6,299
Intangible assets, net 1,526 1,687
Restricted cash - long term 1,078 535
Operating lease right-of-use assets, net 386 506
Other assets 52 53
Total assets 24,143 26,496
Current liabilities:    
Current portion of long-term note 2,693 3,038
Accounts payable 1,560 1,262
Accrued expenses 2,045 2,084
Accrued compensation 1,935 1,071
Billings in excess of revenue earned 4,104 4,163
Accrued warranty 292 370
Income taxes payable 1,723 1,774
Derivative liabilities 484 603
Other current liabilities 831 1,286
Total current liabilities 15,667 15,651
Long-term note, less current portion 0 310
Operating lease liabilities noncurrent 110 160
Other noncurrent liabilities 192 144
Total liabilities 15,969 16,265
Commitments and contingencies (Note 16)
Stockholders' equity:    
Preferred stock $0.01 par value; 2,000,000 shares authorized; no shares issued and outstanding 0 0
Common stock $0.01 par value; 60,000,000 shares authorized, 25,159,719 and 24,046,806 shares issued, 23,560,808 and 22,447,895 shares outstanding, respectively 252 240
Additional paid-in capital 83,860 82,911
Accumulated deficit (72,935) (69,927)
Accumulated other comprehensive (loss) income (4) 6
Treasury stock at cost, 1,598,911 shares (2,999) (2,999)
Total stockholders' equity 8,174 10,231
Total liabilities and stockholders' equity $ 24,143 $ 26,496
v3.23.1
CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares
Mar. 31, 2023
Dec. 31, 2022
Stockholders' equity:    
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01
Preferred stock, shares authorized (in shares) 2,000,000 2,000,000
Preferred stock, shares issued (in shares) 0 0
Preferred stock, shares outstanding (in shares) 0 0
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, shares authorized (in shares) 60,000,000 60,000,000
Common stock, shares issued (in shares) 25,159,719 24,046,806
Common stock, shares outstanding (in shares) 23,560,808 22,447,895
Treasury stock at cost (in shares) 1,598,911 1,598,911
v3.23.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]    
Revenue $ 10,873 $ 12,275
Cost of revenue 8,478 9,848
Gross profit 2,395 2,427
Operating expenses:    
Selling, general and administrative 4,788 4,507
Research and development 181 142
Depreciation 48 72
Amortization of intangible assets 161 260
Total operating expenses 5,178 4,981
Operating loss (2,783) (2,554)
Other income and (expenses), net    
Interest expense, net (286) (148)
Change in fair value of derivative instruments, net 69 (581)
Other income, net 10 16
Loss before income taxes (2,990) (3,267)
(Benefit from) provision for income taxes (39) 167
Net loss $ (2,951) $ (3,434)
Net loss per common share - basic (in dollars per share) $ (0.13) $ (0.16)
Net loss per common share - diluted (in dollars per share) $ (0.13) $ (0.16)
Weighted average shares outstanding used to compute net loss per share - basic (in shares) 22,933,894 20,980,046
Weighted average shares outstanding used to compute net loss per share - diluted (in shares) 22,933,894 20,980,046
v3.23.1
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS [Abstract]    
Net loss $ (2,951) $ (3,434)
Cumulative translation adjustment (10) 181
Comprehensive loss $ (2,961) $ (3,253)
v3.23.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Common Stock [Member]
Common Stock [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Additional Paid-in Capital [Member]
Additional Paid-in Capital [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Accumulated Deficit [Member]
Accumulated Deficit [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Other Comprehensive Loss [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Treasury Stock [Member]
Treasury Stock [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Total
Cumulative Effect, Period of Adoption, Adjustment [Member]
Balance at Dec. 31, 2021 $ 225   $ 80,505   $ (54,584)   $ (104)   $ (2,999)   $ 23,043  
Balance (in shares) at Dec. 31, 2021 22,533               (1,599)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Stock-based compensation expense $ 0   359   0   0   $ 0   359  
Common stock issued for RSUs vested $ 1   (1)   0   0   0   0  
Common stock issued for RSUs vested (in shares) 76                      
Shares withheld to pay taxes $ 0   (86)   0   0   0   (86)  
Foreign currency translation adjustment 0   0   0   181   0   181  
Net (loss) income 0   0   (3,434)   0   0   (3,434)  
Balance at Mar. 31, 2022 $ 226   80,777   (58,018)   77   $ (2,999)   20,063  
Balance (in shares) at Mar. 31, 2022 22,609               (1,599)      
Balance at Dec. 31, 2022 $ 240   82,911   (69,927)   6   $ (2,999)   10,231  
Balance (ASC 326 [Member]) at Dec. 31, 2022 $ 240 $ 0 82,911 $ 0 (69,984) $ (57) 6 $ 0 $ (2,999) $ 0 10,174 $ (57)
Balance (in shares) at Dec. 31, 2022 24,047               (1,599)      
Balance (in shares) (ASC 326 [Member]) at Dec. 31, 2022 24,047 0             (1,599) 0    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Stock-based compensation expense $ 0   274   0   0   $ 0   274  
Common stock issued for RSUs vested $ 2   (2)   0   0   0   0  
Common stock issued for RSUs vested (in shares) 121                      
Shares withheld to pay taxes $ 0   (58)   0   0   0   (58)  
Foreign currency translation adjustment 0   0   0   (10)   0   (10)  
Repayment of convertible note in shares $ 10   735   0   0   0   745  
Repayment of convertible note in shares (in shares) 992                      
Net (loss) income $ 0   0   (2,951)   0   0   (2,951)  
Balance at Mar. 31, 2023 $ 252   $ 83,860   $ (72,935)   $ (4)   $ (2,999)   $ 8,174  
Balance (in shares) at Mar. 31, 2023 25,160               (1,599)      
v3.23.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Cash flows from operating activities:      
Net loss $ (2,951) $ (3,434)  
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:      
Goodwill and intangible asset impairment charge 0 0  
Depreciation 48 72  
Amortization of intangible assets 161 260  
Amortization of capitalized software development costs 84 83  
Amortization of deferred financing costs 7 3  
Amortization of debt discount 303 129  
Loss on debt settled in shares 106 0  
Stock-based compensation expense 285 408  
Credit loss expense 32 0  
Change in fair value of derivative instruments, net (69) 581  
Deferred income taxes 2 55  
Changes in assets and liabilities:      
Contract receivables, net (486) 846  
Prepaid expenses and other assets 876 943  
Accounts payable, accrued compensation and accrued expenses 1,252 1,028  
Billings in excess of revenue earned (61) 150  
Accrued warranty (94) 15  
Other liabilities (336) (56)  
Net cash (used in) provided by operating activities (841) 1,083  
Cash flows from investing activities:      
Capital expenditures 0 (81)  
Capitalized software development costs (77) (106)  
Net cash used in investing activities (77) (187)  
Cash flows from financing activities:      
Repayment of line of credit 0 (1,817)  
Repayment of insurance premium financing (243) (282)  
Proceeds from issuance of long-term debt and warrants 0 5,750  
Payments of debt issuance and original discount on issuance of long-term debt and warrants 0 (968)  
Principal repayment of convertible note (319) 0  
Tax paid for shares withheld (58) (86)  
Net cash (used in) provided by financing activities (620) 2,597  
Effect of exchange rate changes on cash 5 (12)  
Net (decrease) increase in cash, cash equivalents and restricted cash (1,533) 3,481  
Cash, cash equivalents and restricted cash at beginning of the period 4,376 3,550 $ 3,550
Cash, cash equivalents and restricted cash at the end of the period 2,843 7,031 4,376
Cash and cash equivalents 1,265 5,448 2,789
Restricted cash, current 500 0 1,052
Restricted cash included in other long-term assets 1,078 1,583 535
Total cash, cash equivalents and restricted cash 2,843 7,031 $ 4,376
Non-cash financing activities      
Repayment of convertible note in shares 745 0  
Discount on issuance of convertible note $ 0 $ 750  
v3.23.1
Summary of Significant Accounting Policies
3 Months Ended
Mar. 31, 2023
Summary of Significant Accounting Policies [Abstract]  
Summary of Significant Accounting Policies
Note 1 - Summary of Significant Accounting Policies

Basis of Presentation

GSE Systems, Inc. is a leading provider of professional and technical engineering, staffing services and simulation software to clients in the power and process industries. References in this report to “GSE” or “we” or “our” or “the Company” are to GSE Systems, Inc. and our subsidiaries, collectively.

The consolidated interim financial statements included herein have been prepared by GSE and are unaudited. In the opinion of our management, all adjustments and reclassifications of a normal and recurring nature necessary to present fairly the financial position, results of operations and cash flows for the periods presented, have been made. Certain information and note disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) have been condensed or omitted. All intercompany accounts and transactions have been eliminated in consolidation.

The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. GAAP for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. The accompanying balance sheet data for the year ended December 31, 2022 was derived from our audited financial statements, but it does not include all disclosures required by U.S. GAAP.

The results of operations for interim periods are not necessarily an indication of the results for the full year. These consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2022, filed with the U.S. Securities and Exchange Commission on April 17, 2023.

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as reported amounts of revenues and expenses during the reporting period. Our most significant estimates relate to revenue recognition on contracts with customers, product warranties, valuation of goodwill and intangible assets acquired including the determination of fair value in impairment tests, valuation of long-lived assets to be disposed of, valuation of stock-based compensation awards, the recoverability of deferred tax assets, and valuation of warrants and derivative liability related to our convertible note. Actual results of these and other items not listed could differ from these estimates and those differences could be material.

Liquidity and Going Concern

The accompanying consolidated financial statements of the Company have been prepared assuming the Company will continue as a going concern and in accordance with U.S. GAAP. The going concern basis of presentation assumes that the Company will continue in operation one year after the date these financial statements are issued and will be able to realize its assets and satisfy its liabilities and commitments in the normal course of business. Pursuant to the requirements of the Financial Accounting Standards Board’s Accounting Standards Codification (“ASC”) Topic 205-40, Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern, management must evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern for one year from the date these financial statements are issued. This evaluation does not take into consideration the potential mitigating effect of management’s plans that have not been fully implemented or are not within control of the Company as of the date the financial statements are issued. When substantial doubt exists under this methodology, management evaluates whether the mitigating effect of its plans sufficiently alleviates substantial doubt about the Company’s ability to continue as a going concern. The mitigating effect of management’s plans, however, are only considered if both (1) it is probable that the plans will be effectively implemented within one year after the date that the financial statements are issued, and (2) it is probable that the plans, when implemented, will mitigate the relevant conditions or events that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the financial statements are issued. Management determined that the implemented plans to mitigate relevant conditions may not alleviate management's concerns that raise substantial doubt about the Company’s ability to continue as a going concern within the twelve months ended April 30, 2024.

On November 4, 2022, the Company received a notification letter from NASDAQ related to NASDAQ Listing Rules informing us that the Company no longer meets the requirement to maintain a minimum bid price of $1.00 per share. The Company filed a Form 8-K on November 8, 2022, to disclose receipt of this letter. The Company had an initial 180-day period (or until May 3, 2023) to cure this deficiency by maintaining a closing bid price of $1 per share for at least 10 consecutive trading days, and if compliance was not achieved within the initial 180 calendar days we could petition NASDAQ for an additional period of 180 calendar days in which to increase the stock price. Anticipating that it would not regain compliance with the NASDAQ minimum closing bid price requirement by May 3, 2023, on April 19, 2023, the Company submitted a request for an additional 180-day period within which to regain compliance.  On May 4, 2023, the Company received a letter from NASDAQ advising that the 180-day extension – expiring on October 30, 2023 – had been granted due to the facts that the Company:

had met the market value of publicly held shares requirement for continuing listing,
had met all other listing requirements for NASDAQ (other than bid price requirement), and
had provided written notice to NASDAQ with a plan of how it intends to regain compliance with the bid price requirement during the second 180-day period.

The Company’s plan to regain compliance includes continuing to monitor the closing bid price of its Common Stock and, if appropriate, implementing available options including, but not limited to, undertaking a reverse stock split of its outstanding securities at a ratio within the range of one-for-five to one-to-ten, which will have the initial effect of multiplying the trading price of the Company’s Common Stock by the same ratio. Because such an action requires stockholder approval, the Company has put the matter before its stockholders for approval at the 2023 annual meeting of stockholders, which is scheduled to be held on June 12, 2023. If the stockholders approve the measure, we believe that compliance with the NASDAQ minimum bid price listing requirement will be achieved well before the expiration of the second 180-day period.  In furtherance of the Company’s plan to regain compliance, the Company has undertaken the following specific steps:

The Company’s Board of Directors considered and approved a resolution on April 3, 2023, to conduct a reverse stock split of one-for-five to one-to-ten, to put the matter before stockholders at the June 2023 annual meeting, and authorizing Management to file the necessary Proxy Statements to effectuate submission of the matter to stockholders;
The Company filed a Definitive Proxy Statement with the SEC on May 2, 2023 containing this proposal and commenced mailing of notices to stockholders with instructions for obtaining copies of the proxy materials and voting their shares;
Stockholders will vote on the proposed reverse stock split at the annual meeting, which is scheduled to be held on June 12, 2023; and
If the reverse stock split is approved by stockholders, and if the closing bid price on the Company’s Common Stock does not increase, the Board of Directors will cause the Company to effectuate the reverse stock split in a manner intended to achieve compliance well in advance of October 30, 2023.

If compliance is not achieved prior to October 30, 2023, and consequently a delisting letter is issued, the Company may request a hearing before the NASDAQ Hearing Panel with regard to delisting, which may have the effect of staying the delisting and provide the Company with the opportunity to present its further plans to regain compliance. If the Company’s Common Stock ceases to be listed on NASDAQ, Lind Global Fund II LP (“Lind Global”), as the holder of that certain two-year, secured, interest-free convertible promissory note in the amount of $5.75 million (the “Convertible Note”) (see Note 10 for further details), may deliver a notice of event of default together with a demand for payment to the Company for payment in full. If such a demand is delivered, the Company shall, within ten business days, pay all of the outstanding principal amount or, at its election, Lind Global may elect to convert all or a portion of the outstanding principal amount and the conversion price shall be adjusted to the lower of the then-current conversion price and 80% of the average of the three lowest daily variable average weighted prices during the twenty trading days prior to delivery. Additionally, if we are unable to maintain our listing on NASDAQ, it will constitute an event of default under the Convertible Note, which would trigger certain obligations under the Convertible Note including, but not limited to, causing an amount equal to 120% of the outstanding principal amount of the Convertible Note to immediately become due. Although there can be no assurance that the Company will be able to regain compliance with the minimum bid price requirement within the time period(s) permitted by NASDAQ or maintain compliance with any of the other NASDAQ continued listing requirements, we believe we will be able to remediate the noncompliance.

The Company has incurred operating losses and has not demonstrated an ability to generate cash in excess of its operating expenses for a sustained period of time. During the year ended December 31, 2022, the Company generated a loss from operations of $14.4 million, which includes non-cash impairment charges of long-lived assets and goodwill from our Workforce Solutions segment totaling $7.5 million. During the three months ended March 31, 2023, the Company generated a loss from operations of $2.8 million. As of March 31, 2023, the Company had domestic unrestricted cash and cash equivalents of $1.3 million which is not sufficient to fund the Company’s planned operations through one year after the date the consolidated financial statements are issued. These factors create substantial doubt about the Company’s ability to continue as a going concern for at least one year after the date that our audited consolidated financial statements are issued.

In making this assessment we performed a comprehensive analysis of our current circumstances and to alleviate these conditions, management is monitoring the Company’s performance and evaluating strategies to obtain the required additional funding for future operations. These strategies may include, but are not limited to, restructuring of operations to grow revenues and decrease expenses, obtaining equity financing, issuing debt, or entering into other financing arrangements. The analysis used to determine the Company’s ability to continue as a going concern does not include cash sources outside the Company’s direct control that management expects to be available within the next twelve months.
v3.23.1
Recent Accounting Pronouncements
3 Months Ended
Mar. 31, 2023
Recent Accounting Pronouncements [Abstract]  
Recent Accounting Pronouncements
Note 2 - Recent Accounting Pronouncements

Accounting pronouncements recently adopted

In June 2016, the FASB issued ASU 2016-13, Financial Instruments—Credit Losses (Topic 326) to replace the incurred loss impairment methodology under U.S. GAAP. This ASU introduces a new accounting model, the Current Expected Credit Losses model (CECL), which could result in earlier recognition of credit losses and additional disclosures related to credit risk. The CECL model will require the Company to use a forward-looking expected credit loss impairment methodology for the recognition of credit losses for financial instruments at the time the financial asset is originated or acquired, and require a loss be incurred before it is recognized. The expected credit losses are adjusted each period for changes in expected lifetime credit losses. The new standard will apply to accounts receivable, loans, and other financial instruments. This standard is effective for the Company beginning January 1, 2023. The Company adopted the new guidance starting January 1, 2023 on a modified retrospective basis. The impact of this ASU is reflected in the consolidated financial statements and was not material.

Management has evaluated other recently issued accounting pronouncements and does not believe that any of these pronouncements will have a significant impact on our consolidated financial statements and related disclosures.
v3.23.1
Basic and Diluted Loss per Share
3 Months Ended
Mar. 31, 2023
Basic and Diluted Loss per Share [Abstract]  
Basic and Diluted Loss per Share
Note 3 - Basic and Diluted Loss per Share

Basic earnings per share is based on the weighted average number of outstanding common shares for the period. Diluted earnings per share adjusts the weighted average shares outstanding for the potential dilution that could occur if outstanding vested stock options were exercised. Basic and diluted earnings per share are based on the weighted average number of outstanding shares for the period.

The weighted average number of common shares and common share equivalents used in the determination of basic and diluted loss per share were as follows:

(in thousands, except for share amounts)
   Three months ended  
 
 
March 31,
 
   
2023
   
2022
 
Numerator:
           
Net loss attributed to common stockholders
  $ (2,951
)
  $ (3,434
)
                 
Denominator:
               
Weighted-average shares outstanding for basic earnings per share
    22,933,894
      20,980,046
 
                 
Adjusted weighted-average shares outstanding and assumed conversions for diluted earnings per share
    22,933,894
      20,980,046
 
                 
Shares related to potentially dilutive securities excluded because inclusion would be anti-dilutive
    2,856,032
      149,271
 
v3.23.1
Coronavirus Aid, Relief and Economic Security Act
3 Months Ended
Mar. 31, 2023
Coronavirus Aid, Relief and Economic Security Act [Abstract]  
Coronavirus Aid, Relief and Economic Security Act
Note 4 - Coronavirus Aid, Relief and Economic Security Act

Employee Retention Credits (ERC)

Employee retention tax credits, made available under the CARES Act, allow eligible employers to claim a refundable tax credit against the employer share of Social Security tax equal to 70% of the qualified wages they pay to employees, initially from March 27, 2020 until June 30, 2021, and extended through September 30, 2021. In 2021, we applied for $5.0 million in refunds from the Internal Revenue Service with filing of our 941s and achieved $2.2 million in credits from unremitted payroll taxes as allowed. We recorded other income of $7.2 million related to the employee retention tax credits earned for the year ended December 31, 2021. As of March 31, 2023, we received cumulative employee retention tax credit refunds totaling $4.9 million of the $5.0 million in refunds sought, with remaining outstanding refunds receivable of $0.1 million which was included in the other current assets balance at March 31, 2023.
v3.23.1
Contract Receivables
3 Months Ended
Mar. 31, 2023
Contract Receivables [Abstract]  
Contract Receivables
Note 5 - Contract Receivables

Contract receivables represent our unconditional rights to consideration due from our domestic and international customers. We expect to collect all contract receivables within the next twelve months.

The components of contract receivables were as follows:

(in thousands)
 
March 31, 2023
   
December 31, 2022
 
             
Billed receivables
 
$
5,831
   
$
6,074
 
Unbilled receivables
   
5,859
     
5,146
 
Allowance for credit loss
   
(1,226
)
   
(1,156
)
Total contract receivables, net
 
$
10,464
   
$
10,064
 

During the fist quarter of 2023, the Company adopted ASU 2016-13, “Credit Losses (Topic 326) Measurement of Credit Losses on Financial Instruments.” This ASU replaces the incurred loss impairment model with an expected credit loss impairment model for financial instruments, including accounts receivable. Under the new guidance, an entity recognizes its estimate of lifetime expected credit losses as an allowance, which the FASB believes will result in more timely recognition of such losses. Under the CECL impairment model, the Company develops and documents its allowance for credit losses on its contract receivables based on three portfolio segments by customer geographic location:  North America, China, Rest of World (ROW). The determination of portfolio segments is based primarily on the qualitative consideration of the nature of the Company’s business operations and the characteristics of the underlying trade receivables.


The following table sets forth the activity in the allowance for credit losses for the three months ended March 31, 2023.


(in thousands)
     
Beginning balance at January 1, 2023
 
$
1,213
 
Current period provision for expected credit loss
   
9
 
Write-offs charged against the allowance, net of recoveries
   
-
 
Currency adjustment
    4  
Balance at March 31, 2023
 
$
1,226
 

During the three months ended March 31, 2023, we recorded credit loss expense of $32 thousand. We recorded no credit loss expense during the three months ended March 31, 2022.

During the month of April 2023, we invoiced $3.0 million of the unbilled receivables as of March 31, 2023.

Our foreign currency denominated contract receivables, billings in excess of revenue earned and subcontractor accruals that are related to the outstanding foreign exchange contracts are remeasured at the end of each reporting period into our functional currency, using the current exchange rate at the end of the period. The gain or loss resulting from such remeasurement is included in other income, net in the consolidated statements of operations. During the three months ended March 31, 2023 and 2022, we recognized a gain on remeasurement of these foreign exchange contracts of $72 thousand and $3 thousand, respectively.

As of March 31, 2023, we had one customer that accounted for 17% of our consolidated contract receivables. As of December 31, 2022, we had no customer that accounted for 10% of our consolidated contract receivables.
v3.23.1
Goodwill and Intangible Assets
3 Months Ended
Mar. 31, 2023
Goodwill and Intangible Assets [Abstract]  
Goodwill and Intangible Assets
Note 6 - Goodwill and Intangible Assets

The Company monitors operating results and events and circumstances that may indicate potential impairment of intangible assets. Management concluded that no triggering events that occurred during the three months ended March 31, 2023 and 2022.

During September 30, 2022, we determined that the deterioration in sales, decline in revenues, delayed pipeline opportunities, and overall downward performance results and the forecast related to the Workforce Solutions business segment was material enough to be considered a triggering event that could result in impairment of our long-lived assets. We performed an interim analysis and determined an impairment existed at September 30, 2022 in accordance with ASC 350 & ASC 360. As such, we recorded an impairment of the related goodwill and definite-lived intangible assets of $7.0 million and $0.5 million, for the three and nine months ended September 30, 2022, respectively.

Management determined there were no triggering events occured during the three months March 31, 2023.

Goodwill

The following table shows the gross carrying amount and impairment of goodwill:

(in thousands)

 
 
Goodwill
   
Accumulated
Impairment
   
Net
 

                 
Engineering
 
$
8,278
   
$
(3,370
)
 
$
4,908
 
Workforce Solutions
   
8,431
     
(7,040
)
   
1,391
 
Net book value at March 31, 2023
 
$
16,709
   
$
(10,410
)
 
$
6,299
 

(in thousands)

 
 
Goodwill
   
Accumulated
Impairment
   
Net
 

                 
Engineering
 
$
8,278
   
$
(3,370
)
 
$
4,908
 
Workforce Solutions
   
8,431
     
(7,040
)
   
1,391
 
Net book value at December 31, 2022
 
$
16,709
   
$
(10,410
)
 
$
6,299
 

The following table shows the gross carrying amount and accumulated amortization of definite-lived intangible assets:

(in thousands)
 
As of March 31, 2023
 
   
Gross
Carrying
Amount
   
Accumulated
Amortization
     Impairment    
Net
 
Amortized intangible assets:
                       
Customer relationships
 
$
8,628
   
$
(7,154
)
  $
(464 )  
$
1,010
 
Trade names
   
1,689
     
(1,218
)
    -      
471
 
Developed technology
   
471
     
(471
)
    -      
-
 
Non-contractual customer relationships
   
433
     
(433
)
    -      
-
 
Noncompete agreement
   
527
     
(495
)
    -      
32
 
Alliance agreement
   
527
     
(514
)
    -      
13
 
Others
   
167
     
(167
)
    -      
-
 
Total
 
$
12,442
   
$
(10,452
)
  $ (464 )  
$
1,526
 

(in thousands)
 
As of December 31, 2022
 
   
Gross
Carrying
Amount
   
Accumulated Amortization
   
Impairment
   
Net
 
Amortized intangible assets:
                       
Customer relationships
 
$
8,628
   
$
(7,050
)
 
$
(464
)
 
$
1,114
 
Trade names
   
1,689
     
(1,196
)
   
-
     
493
 
Developed technology
   
471
     
(471
)
   
-
     
-
 
Non-contractual customer relationships
   
433
     
(433
)
   
-
     
-
 
Noncompete agreement
   
527
     
(486
)
   
-
     
41
 
Alliance agreement
   
527
     
(488
)
   
-
     
39
 
Others
   
167
     
(167
)
   
-
     
-
 
Total
 
$
12,442
   
$
(10,291
)
 
$
(464
)
 
$
1,687
 

Amortization expense related to definite-lived intangible assets totaled $0.2 million and $0.3 million for the three months ended March 31, 2023 and 2022. The following table shows the estimated amortization expense of the definite-lived intangible assets for the next five years and thereafter:
 
(in thousands)
     
Years ended December 31:
     
2023 remainder
 
$
348
 
2024
   
332
 
2025
   
255
 
2026
   
204
 
2027
   
169
 
Thereafter
   
218
 
Total
 
$
1,526
 
v3.23.1
Equipment, Software and Leasehold Improvements
3 Months Ended
Mar. 31, 2023
Equipment, Software and Leasehold Improvements [Abstract]  
Equipment, Software and Leasehold Improvements
Note 7 - Equipment, Software and Leasehold Improvements

Equipment, software and leasehold improvements, net consist of the following:

(in thousands)
           
   
March 31, 2023
   
December 31, 2022
 
Computer and equipment
 
$
2,363
   
$
2,363
 
Software
   
2,291
     
2,291
 
Leasehold improvements
   
659
     
659
 
Furniture and fixtures
   
839
     
838
 
     
6,152
     
6,151
 
Accumulated depreciation
   
(5,428
)
   
(5,379
)
Equipment, software and leasehold improvements, net
 
$
724
   
$
772
 

Depreciation expense was $48 thousand and $72 thousand for the three months ended March 31, 2023 and 2022, respectively.
v3.23.1
Fair Value of Financial Instruments
3 Months Ended
Mar. 31, 2023
Fair Value of Financial Instruments [Abstract]  
Fair Value of Financial Instruments
Note 8 - Fair Value of Financial Instruments

ASC 820, Fair Value Measurement, defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.

The levels of the fair value hierarchy established by ASC 820 are:

Level 1:  inputs are quoted prices, unadjusted, in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.

Level 2:  inputs are other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. A Level 2 input must be observable for substantially the full term of the asset or liability.

Level 3:  inputs are unobservable and reflect the reporting entity’s own assumptions about the assumptions that market participants would use in pricing the asset or liability.

As of March 31, 2023 and December 31, 2022, we considered the recorded value of certain of our financial assets and liabilities, which consist primarily of cash and cash equivalents, contract receivable and accounts payable, to approximate fair value based upon their short-term nature.

Our convertible debt issued in February 2022 (See Note 10) includes certain embedded redemption features that are required to be bifurcated as embedded derivatives and measured at fair value on a recurring basis. We estimate the fair value using a Monte Carlo simulation based on estimates of our future stock price and assumptions about the possible redemption scenarios.

The Company used the Monte Carlo simulation model to determine the fair value of the Warrants and Cash-Settled PRSUs, which required the input of subjective assumptions. The fair value of the Warrants as of March 31, 2023 was estimated with the following assumptions.
 
Exercise Price
$ 1.94  
       
Common Stock Price
$ 0.70  
Risk Free Rate
  3.6 %
Volatility
  70.0 %
Term (in years)

3.9 yrs.  

The following table presents assets and liabilities measured at fair value at March 31, 2023:

(in thousands)
 
Quoted Prices
in Active Markets
for Identical Assets
(Level 1)
   
Significant
Other Observable
Inputs
(Level 2)
   
Significant
Unobservable
Inputs
(Level 3)
   
Total
 
                         
Derivative liability   $ -     $ -     $ 217     $ 217  
Warrant liability
    -       -       267       267  
Cash settled performance-vesting restricted stock units
    -       -       62       62  
 Total liabilities   $ -     $ -     $ 546     $ 546  

The following table presents assets and liabilities measured at fair value at December 31, 2022:

(in thousands)
 
Quoted Prices
in Active Markets
for Identical Assets
(Level 1)
   
Significant
Other Observable
Inputs
(Level 2)
   
Significant
Unobservable
Inputs
(Level 3)
   
Total
 
                         
Derivative liability   $ -     $ -     $ 285     $ 285  
Warrant liability
    -       -       267       267  
Cash settled performance-vesting restricted stock units
    -       -       51       51  
 Total liabilities   $ -     $ -     $ 603     $ 603  

The following table summarizes changes in the fair value of our Level 3 liabilities during the three months ended March 31, 2023.

(in thousands)
 
Embedded
Redemption Features
    Warrant    
Cash Settled
PRSUs
    Level 3 Total
 
Balance at December 31, 2022
 
$
285
    $ 267     $ 51     $ 603  
Change in FV included in gain on derivative instruments, net
    (68 )     -       -       (68 )
Stock compensation less payments made
    -
      -
      11
      11
 
Balance at March 31, 2023
 
$
217
    $ 267     $ 62     $ 546  
v3.23.1
Stock-Based Compensation
3 Months Ended
Mar. 31, 2023
Stock-Based Compensation [Abstract]  
Stock-Based Compensation
Note 9 - Stock-Based Compensation

We recognize compensation expense on a pro rata straight-line basis over the requisite service period for stock-based compensation awards with both graded and cliff vesting terms. We recognize the cumulative effect of a change in the number of awards expected to vest in compensation expense in the period of change. We have not capitalized any portion of our stock-based compensation. Our forfeiture rate is based on actuals.


During the three months ended March 31, 2023 and 2022, we recognized $0.3 million and $0.4 million of stock-based compensation expense related to equity awards, respectively, under the fair value method.



During the three months ended March 31, 2023, we granted approximately 45,000 restricted stock units (“RSUs”) with an aggregate fair value of approximately $33 thousand. During the three months ended March 31, 2022, we granted approximately 14,000 time-based RSUs with an aggregate fair value of approximately $24 thousand, respectively. During the three months ended March 31, 2023, we vested 184,949 RSUs compared to 121,540 RSUs vested during the three months ended March 31, 2022. A portion of the time-based RSUs vest quarterly in equal amounts over the course of eight quarters, and the remainder vest annually in equal amounts over the course of one to three years.

GSE’s 1995 long-term incentive program (“LTIP”) provides for the issuance of performance-vesting and time-vesting RSUs to certain executives and employees. Vesting of the performance-vesting restricted stock units (“PRSU”) is contingent upon the employee’s continued employment and the Company’s achievement of certain performance goals during designated performance periods as established by the Compensation Committee of the Company’s Board of Directors. We recognize compensation expense, net of estimated forfeitures, for PRSUs on a straight-line basis over the performance period based on the probable outcome of achievement of the financial targets. At the end of each reporting period, we estimate the number of PRSUs that are expected to vest, based on the probability and extent to which the performance goals will be met, and take into account these estimates when calculating the expense for the period. If the number of shares expected to be earned changes during the performance period, we make a cumulative adjustment to compensation expense based on the revised number of shares expected to be earned.

During the three months ended March 31, 2023, there were no PRSUs granted compared to 800,000 during the three months ended March 31, 2022, including 200,000 cash-settled grants to employees. These grants are subject to multiple vesting criteria including reaching a 20-day VWAP of $1.94 prior to the expiration of the awards, and a time-vesting restriction, which will vest in equal portions over the next 15 quarters ending December 31, 2025. During the three months ended March 31, 2023, we vested 50,000 PRSUs, of which, 12,500 PRSUs were cash-settled, respectively. No PRSUs were vested during the three months ended March 31, 2022. The market vesting criteria was achieved in April 2022 for the 800,000 PRSUs which will fully vest over the next 11 quarters.

We did not grant any stock options for the three months ended March 31, 2023 and 2022.
v3.23.1
Debt
3 Months Ended
Mar. 31, 2023
Debt [Abstract]  
Debt
Note 10 - Debt

Convertible Note

On February 23, 2022, we entered into a Securities Purchase Agreement, as amended, with Lind Global, pursuant to which we issued to Lind Global the Convertible Note (see Note 1) and a common stock purchase warrant to acquire 1,283,732 shares of our Common Stock (the “Warrant”). The Convertible Note does not bear interest but was issued at a $0.75 million discount (“OID”). We received proceeds of approximately $4.8 million net of the OID and expenses.

   
Amount
 
       
Convertible Note issued
 
$
5,750
 
Debt discount
   
(750
)
Issuance cost:
       
Commitment fee
   
(175
)
Balance of investor’s counsel fees
   
(43
)
Net proceeds of Convertible Note
 
$
4,782
 

       
Fair value of Warrant Liabilities on issuance
    (724 )
Fair value of Conversion Feature on issuance
    (306 )
Allocated OID costs to Convertible Note
    (96 )
Interest expense accrued on Convertible Note as of March 31, 2023
    1,592  
Principal and interest payments through March 31, 2023     (2,555 )
         
Balance of Convertible Note as of March 31, 2023   $ 2,693  

The Convertible Note provides for 18 monthly principal repayments of $319 thousand beginning 180 days from issuance.  Payments can be made in the form of cash, shares, or a combination of both at the discretion of GSE.

The Convertible Note is convertible into our Common Stock at any time after the earlier of six months from issuance of the Convertible Note or the date of an effective registration statement filed with the SEC covering the underlying shares. The conversion price of the Convertible Note is initially equal to $1.94 per share, subject to customary adjustments. The Convertible Note matures in February of 2024, although we are permitted to prepay the Convertible Note, provided that Lind Global shall have the option to convert up to one third of the outstanding principal of the Convertible Note at a price per share equal to the lessor of the Repayment Share price or the conversion price (as described below). The Convertible Note is guaranteed by each of our subsidiaries and is secured by a first priority lien on all of our assets. The Convertible Note is not subject to any financial covenants and events of default under the Convertible Note are limited to events related to payment, market capitalization, certain events pertaining to conversion and the underlying shares of Common Stock and other customary events including, but not limited to, bankruptcy or insolvency. Upon the occurrence of an event of default, the Convertible Note will become immediately due and payable at an amount equal to 120% of the outstanding principal, subject to any cure periods described in the Convertible Note, and the customer may demand that all or a portion of the outstanding principal amount be converted into shares of common stock at the lower of the then current conversion price and 80% of the average of the three lowest daily volume-weighted average price (“VWAPs”) during the twenty days prior to delivery of the conversion notice. If there is a change of control of the Company, Lind Global has the right to require us to prepay the outstanding principal amount of the Convertible Note.

A portion of the proceeds of the Convertible Note were used to repay, in full, all outstanding indebtedness owed to Citizens Bank, N.A. (“Citizens”), and the Amended and Restated Credit and Security Agreement between us, our subsidiaries, and Citizens was terminated. We will continue to maintain a cash management account and certain letters of credit with Citizens and, accordingly, have entered into a certain Cash Management Agreement with Citizens, as well as certain Cash Pledge Agreements in amounts corresponding to the current outstanding letters of credits with customers.

The Warrant entitles Lind Global to purchase up to 1,283,732 shares of our Common Stock until February 23, 2027, at an exercise price of $1.94 per share, subject to customary adjustments described therein.  The Warrant is recorded at fair value upon issuance of $0.7 million and is classified as a current liability to be remeasured at each reporting period (see Note 8). The discount created by allocating proceeds to the Warrant results in a debt discount to be amortized as additional interest expense over the term of the Convertible Note.

The Company evaluated the Convertible Note and concluded that certain embedded redemption features are required to be accounted for as a derivative liability. Embedded redemption features were recorded at fair value upon issuance of $0.3 million and are classified as current liabilities to be remeasured at each reporting period (see Note 8). The discount created by allocating proceeds to the derivative liability results in a debt discount to be amortized as additional interest expense over the term of the Convertible Notes. The Warrant is accounted for as a derivative liability based on certain features included within the Convertible Note which caused the Company to not be able to assert that it would have sufficient shares in all cases to be able to settle the warrant. As such, the initial proceeds (approximately $4.8 million, net of original issue discounts and other payments to lender) were allocated first to the fair value of the Warrant with the residual allocated to the Convertible Note host instrument. The proceeds allocated to the Convertible Note were further allocated first to the bifurcated derivative liability based on its fair value with the residual being allocated to the Convertible Note host instrument.

The direct and incremental costs incurred are allocated to the Convertible Note and the Warrant based on a systematic and rational approach. The costs allocated to the Warrant have been expensed as incurred while those allocated to the Convertible Note have been capitalized and will be amortized as interest expense over the life of the Convertible Note based on the effective interest rate. The Company will record ongoing changes to the fair value of the derivative liabilities as other non-operating income (expense).

The Convertible Note was evaluated as a potentially dilutive security in both periods of loss and income for diluted earnings per share purposes. The Warrant is considered a participating security and was not included in the calculation of basic earnings per share for the period ended March 31, 2023 as Company reflected net loss for this period. The Warrant will be included in the calculation of basic earnings per share in periods of net income.

The issuance costs with respect to the Convertible Note, which are recorded as a debt discount, are deferred and amortized using effective interest method as additional interest expense over the terms of the Convertible Note.

The Company incurred total interest expense related to the Convertible Note, including the amortization of the various discounts, of $303 thousand for the three months ended March 31, 2023, respectively.

Revolving Line of Credit

In February 2022, using proceeds from the Convertible Note, we repaid in full, all outstanding indebtedness of $1.8 million owed to Citizens, and the Amended and Restated Credit and Security Agreement between us, our subsidiaries, and Citizens was terminated. Certain letters of credit remain in place with Citizens. As of March 31, 2023, we had five letters of credit totaling $1.1 million outstanding to certain customers which were secured with restricted cash.
v3.23.1
Product Warranty
3 Months Ended
Mar. 31, 2023
Product Warranty [Abstract]  
Product Warranty
Note 11 - Product Warranty

We accrue estimated warranty costs at the time the related revenue is recognized and based on historical experience and projected claims. Our System Design and Build contracts generally include a one year base warranty on the systems. The portion of our warranty provision expected to be incurred within twelve months is classified as current within accrued warranty and totals $292 thousand, and the remaining $117 thousand is classified as long-term within other non-current liabilities.

The activity in the accrued warranty accounts during the current period is as follows:

(in thousands)
     
Balance at January 1, 2023
 
$
503
 
Current period recovery
   
(75
)
Current period claims
   
(18
)
Currency adjustment
   
(1
)
Balance at March 31, 2023
 
$
409
 
v3.23.1
Revenue
3 Months Ended
Mar. 31, 2023
Revenue [Abstract]  
Revenue
Note 12 - Revenue

We account for revenue in accordance with ASC 606, Revenue from Contracts with Customers. We primarily generate revenue through three distinct revenue streams: (1) System Design and Build (“SDB”), (2) Software and (3) Training and Consulting Services across our Performance Improvement Solutions and Workforce Solutions segments. We recognize revenue from SDB and software contracts mainly through our Performance Improvement Solutions segment. We recognize training and consulting service contracts through both segments.

The following table represents a disaggregation of revenue by type of goods or services for the three months ended March 31, 2023 and 2022, along with the reportable segment for each category:

 
 
Three months ended
 
(in thousands)  
March 31, 2023
   
March 31, 2022
 
Engineering
           
System Design and Build - Over time
 
$
1,470    
$
1,412  
     
     
 
Software and Support
    1,189       372  
Point in time
    313       45  
Over time
    876       327  
     
     
 
Training and Consulting Services
    4,282       4,613  
Point in time
    196       418  
Over time
    4,086       4,195  
     
     
 
Workforce Solutions
   
     
 
Training and Consulting Services
    3,932       5,878  
Point in time
    119       -  
Over time
    3,813       5,878  
     
     
 
Total revenue
 
$
10,873    
$
12,275  

The following table reflects the revenue recognized in the reporting periods that were included in contract liabilities from contracts with customers:

(in thousands)  
Three months ended
 
   
March 31, 2023
   
March 31, 2022
 
Revenue recognized in the period from amounts included in Billings in Excess of Revenue Earned at the beginning of the period
 
$
1,850
   
$
1,456
 
v3.23.1
Income Taxes
3 Months Ended
Mar. 31, 2023
Income Taxes [Abstract]  
Income Taxes
Note 13 - Income Taxes

The following table shows the provision for (benefit from) income taxes and our effective tax rates:

(in thousands)
 
Three months ended
 
   
March 31, 2023
   
March 31, 2022
 
(Loss) income before income taxes
 
$
(2,990
)
 
$
(3,267
)
(Benefit from) provision for income taxes
   
(39
)
   
167
 
Effective tax rate
   
1.3
%
   
(5.1
)%

Our income tax expense or benefit for the interim periods presented is determined using an estimate of our annual effective tax rate, adjusted for discrete items arising in that quarter. Total income tax expense for the three months ended March 31, 2023 was comprised mainly of current foreign and state tax expense, as well as deferred state tax expense related to the portion of goodwill which cannot be offset by deferred tax assets. Total income tax expense for the three months ended March 31, 2022 was comprised mainly foreign and state tax expense, as well as deferred federal and state tax expense related to the portion of goodwill which cannot be offset by deferred tax assets.

Our income effective tax rate was 1.3% and (5.1)% for the three months ended March 31, 2023 and 2022, respectively. For the three months ended March 31, 2023, the difference between our income tax benefit at an effective tax rate of 1.3% and a benefit at the U.S. statutory federal income tax rate of 21% was primarily due to a change in valuation allowance in our U.S. entity, the permanent disallowance of interest expense related to disqualified debt, accruals related to uncertain tax positions for certain foreign tax contingencies, and discrete item adjustments for U.S. and foreign taxes. For the three months ended March 31, 2022, the difference between income tax expense at an effective tax rate of (5.1)% and a benefit at the U.S. statutory federal income tax rate of 21% was primarily due to a change in valuation allowance in our U.S. entity, the permanent disallowance of interest expense related to disqualified debt, accruals related to uncertain tax positions for certain foreign tax contingencies, and discrete item adjustments for U.S. and foreign taxes.

Because of our net operating loss carryforwards, we are subject to U.S. federal and state income tax examinations from the year 2003 and forward and are subject to foreign tax examinations by tax authorities for years 2017 and forward.

An uncertain tax position taken or expected to be taken in a tax return is recognized in the consolidated financial statements when it is more likely than not (i.e., a likelihood of more than 50%) that the position would be sustained upon examination by tax authorities that have full knowledge of all relevant information. A recognized tax position is then measured at the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement. Interest and penalties related to income taxes are accounted for as income tax expense.

We recognize deferred tax assets to the extent that it is believed that these assets are more likely than not to be realized. We have evaluated all positive and negative evidence and determined that it will continue to assess a full valuation allowance on our U.S., Chinese, and Slovakian net deferred assets as of March 31, 2023. We have determined that it is not more likely than not that the Company will realize the benefits of its deferred taxes in the U.S. and foreign jurisdictions.
v3.23.1
Leases
3 Months Ended
Mar. 31, 2023
Leases [Abstract]  
Leases
Note 14 - Leases

We have lease agreements with lease and non-lease components, which are accounted for as a single lease. We apply a portfolio approach to effectively account for the operating lease ROU assets and liabilities. The operating lease ROU amortization was $120 thousand and $153 thousand for the three months ended March 31, 2023 and 2022, respectively.

Lease contracts are evaluated at inception to determine whether they contain a lease and whether we obtain the right to control an identified asset. The following table summarizes the classification of operating ROU assets and lease liabilities on the consolidated balance sheets:

(in thousands)
 
      As of
 
Operating Leases
 
Classification
 
March 31, 2023
   
December 31, 2022
 
                 
Leased Assets
               
Operating lease - right of use assets
 
Long term assets
 
$
386
   
$
506
 
                     
Lease Liabilities
                   
Operating lease liabilities - Current
 
Other current liabilities
   
306
     
418
 
Operating lease liabilities
 
Long term liabilities
   
110
     
160
 
         
$
416
   
$
578
 

We entered into a lease agreement to lease 2,200 square feet of office space on September 26, 2022, and the lease term will end on November 30, 2024. On December 15, 2022, we terminated our lease for 1332 Londontown Boulevard, Eldersburg, Maryland (our former headquarters) and entered into a release and settlement agreement whereby we agreed to pay, and the landlord agreed to accept, a reduced monthly payment through May 1, 2023 in exchange for early termination of the lease. As a part of this agreement, we assigned both active subleases to the landlord effective as of the execution date.

The table below summarizes lease income and expense recorded in the consolidated statements of operations incurred during three months ended March 31, 2023 and 2022, (in thousands):

           
Three months ended
 
Lease Cost
 
Classification
 
March 31, 2023
   
March 31, 2022
 
                 
Operating lease cost (1)
 
Selling, general and administrative expenses